
Topical peptides: formulation matters too
A formulation, a measurement site and a defined outcome tell us more than a broad penetration promise.
Moving from an ingredient list to a testable question.
A formulation, a measurement site and a defined outcome tell us more than a broad penetration promise.
Key points / Puntos clave
- The result belongs to a defined formulation.
- Penetration and benefit are different questions.
- A regulatory claim needs a country and intended use.
Read the complete product
Two packages can name the same ingredient while telling different scientific stories. The reader’s first task is to identify the product actually studied: formulation, reported concentration, assessment method and comparison. Keeping that identity prevents a result from one preparation being attributed to every mixture. Recognizing a word on the label is not enough.
Penetration needs a location
OECD 428 studies absorption using skin and a diffusion cell. Material location belongs in the result; finding it there does not establish clinical benefit.
The comparator can share the base
Robinson and colleagues studied a pal-KTTKS formula against its base in 2005. The short reading retains the population and design of that comparison.
A photograph has conditions too
For photographic comparisons, we propose recording lighting, position, expression, interval and assessment procedure. These are editorial reading questions, not a validated protocol. If the details are absent, a visual impression may be interesting, but it should not be presented as an exact measurement. An attractive figure cannot replace the method explaining how it was produced.
The kind of claim matters
FDA explains that intended use helps distinguish cosmetics from drugs in the United States. An appearance claim and a disease-treatment claim need separate readings. This distinction belongs to that US framework; it does not establish a product’s status throughout the Americas. A regulatory review starts with country, product and claim.
Return to the original question
Next time a headline highlights a topical peptide, look for four details: the formulation, measurement location, changed outcome and comparison. If the study answers only one question, keep that scope. This lets us value cosmetic research without turning it into a promise of repair, systemic absorption or treatment.
Imagine two advertisements citing the same ingredient: one refers to cell culture and another to photographs of a finished formula. Record the sources on separate lines. The task is not to decide which package to buy; it is to detect whether the claim matches the product and outcome studied.
Also review image language. “Material was detected” needs a location; “appearance improved” needs an appearance assessment. Conceptual skin artwork should be identified as such and should not stand in for an experimental photograph. Keeping that distinction makes a summary easier to review later.
Professional context / Contexto profesional
Distinguish skin retention, permeation and outcome; do not extrapolate between formulations without data.
Evidence / Evidencia
Educational synthesis using an OECD method, a historical cosmetic trial and FDA’s claims framework.
Limitations / Limitaciones
Does not recommend brands, barrier-altering techniques or use on injured skin.
References
- OECD. Test No. 428: Skin Absorption: In Vitro Method. OECD Guidelines for the Testing of Chemicals, Section 4. 2004
- Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science. 2005
- U.S. Food and Drug Administration. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)